US FDA’s ODAC Pushes Back Against ‘Leading’ Questions

 
• By Michael McCaughan
  
question
Did the FDA push ODAC too much with its voting question on Pepaxto? • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers